| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial
|
Rossi, David
|
|
2010
|
5 |
4 |
p. 231-235
|
article
|
| 2 |
EGFR inhibitors in non-small cell lung cancer (NSCLC): the emerging role of the dual irreversible EGFR/HER2 inhibitor BIBW 2992
|
Spicer, James F.
|
|
2010
|
5 |
4 |
p. 245-255
|
article
|
| 3 |
Examining the safety profile of angiogenesis inhibitors: implications for clinical practice
|
Reck, Martin
|
|
2010
|
5 |
4 |
p. 257-267
|
article
|
| 4 |
Investigation of the efficacy of a bevacizumab-cetuximab-cisplatin regimen in treating head and neck squamous cell carcinoma in mice
|
Wang, Yixiang
|
|
2010
|
5 |
4 |
p. 237-243
|
article
|
| 5 |
Personalized medicine in lung adenocarcinoma: no longer a hope or a passing fashion, but a new reality
|
Morère, Jean-François
|
|
2010
|
5 |
4 |
p. 229-230
|
article
|
| 6 |
Targeting mTOR in cancer: renal cell is just a beginning
|
Azim, Hamdy
|
|
2010
|
5 |
4 |
p. 269-280
|
article
|
| 7 |
Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy
|
Driscoll, James J.
|
|
2010
|
5 |
4 |
p. 281-289
|
article
|
| 8 |
Tufted hair folliculitis in a woman treated with trastuzumab
|
Rosman, Ilana S.
|
|
2010
|
5 |
4 |
p. 295-296
|
article
|
| 9 |
Use of rituximab in three children with relapsed/refractory Burkitt lymphoma
|
Akbayram, Sinan
|
|
2010
|
5 |
4 |
p. 291-294
|
article
|
Journal description